|
US4513006A
(en)
*
|
1983-09-26 |
1985-04-23 |
Mcneil Lab., Inc. |
Anticonvulsant sulfamate derivatives
|
|
US4727064A
(en)
*
|
1984-04-25 |
1988-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Pharmaceutical preparations containing cyclodextrin derivatives
|
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
|
PH31594A
(en)
|
1993-09-30 |
1998-11-03 |
Janssen Pharmaceutica Nv |
Oral formulations on an antifungal.
|
|
US5500227A
(en)
*
|
1993-11-23 |
1996-03-19 |
Euro-Celtique, S.A. |
Immediate release tablet cores of insoluble drugs having sustained-release coating
|
|
US5576311A
(en)
*
|
1994-11-30 |
1996-11-19 |
Pharmos Corporation |
Cyclodextrins as suspending agents for pharmaceutical suspensions
|
|
US5998380A
(en)
*
|
1995-10-13 |
1999-12-07 |
New England Medical Center Hospitals, Inc. |
Treatment of migraine
|
|
US5753693A
(en)
|
1996-06-28 |
1998-05-19 |
Ortho Pharmaceutical Corporation |
Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder
|
|
GB9711643D0
(en)
*
|
1997-06-05 |
1997-07-30 |
Janssen Pharmaceutica Nv |
Glass thermoplastic systems
|
|
US5760007A
(en)
*
|
1997-07-16 |
1998-06-02 |
Ortho Pharmaceutical Corporation |
Anticonvulsant derivatives useful in treating neuropathic pain
|
|
US5935933A
(en)
*
|
1997-07-16 |
1999-08-10 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivatives useful in treating neuropathic pain
|
|
US20040028735A1
(en)
*
|
1997-11-14 |
2004-02-12 |
Unchalee Kositprapa |
Pharmaceutical formulation
|
|
UA65607C2
(uk)
*
|
1998-03-04 |
2004-04-15 |
Орто-Макнейл Фармацевтикал, Інк. |
Фармацевтична композиція (варіанти) та спосіб її приготування
|
|
US6524620B2
(en)
*
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
|
CA2348871C
(en)
*
|
1998-11-02 |
2009-04-14 |
John G. Devane |
Multiparticulate modified release composition
|
|
EP1005863A1
(en)
*
|
1998-12-04 |
2000-06-07 |
Synthelabo |
Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
|
|
IL144406A0
(en)
*
|
1999-01-19 |
2002-05-23 |
Ortho Mcneil Pharm Inc |
Anticonvulsant derivatives useful in treating cluster headaches
|
|
US7374779B2
(en)
*
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
US6294192B1
(en)
*
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
MXPA01010221A
(es)
*
|
1999-04-08 |
2002-03-27 |
Johnson & Johnson |
Derivados anticonvulsivos utiles para disminuir la presion sanguinea.
|
|
US7056890B2
(en)
*
|
1999-06-14 |
2006-06-06 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
|
JP4977297B2
(ja)
*
|
1999-08-20 |
2012-07-18 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
トラマドール物質及び抗痙攣薬を含んで成る組成物
|
|
US6479467B1
(en)
*
|
1999-12-16 |
2002-11-12 |
Eastman Chemical Company |
Cyclodextrin ethers
|
|
SE0000601D0
(sv)
*
|
2000-02-24 |
2000-02-24 |
Jan Hedner |
Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
|
|
DK1309324T3
(da)
*
|
2000-07-07 |
2006-06-12 |
Ortho Mcneil Pharm Inc |
Antikonvulsive derivater egnede til behandling og forebyggelse af udvikling af type II diabetes mellitus og syndrom X
|
|
US6191117B1
(en)
|
2000-07-10 |
2001-02-20 |
Walter E. Kozachuk |
Methods of producing weight loss and treatment of obesity
|
|
US6344215B1
(en)
*
|
2000-10-27 |
2002-02-05 |
Eurand America, Inc. |
Methylphenidate modified release formulations
|
|
AU2002253838B2
(en)
*
|
2000-10-30 |
2006-11-09 |
Ortho-Mcneil Pharmaceutical, Inc. |
Combination therapy comprising anti-diabetic and anticonvulsant agents
|
|
US20020082222A1
(en)
*
|
2000-11-30 |
2002-06-27 |
Shapira Nathan Andrew |
Treatments for neurogenetic disorders, impulse control disorder, and wound healing
|
|
TWI321054B
(en)
*
|
2000-12-19 |
2010-03-01 |
California Inst Of Techn |
Compositions containing inclusion complexes
|
|
US6500454B1
(en)
*
|
2001-10-04 |
2002-12-31 |
Eurand Pharmaceuticals Ltd. |
Timed, sustained release systems for propranolol
|
|
US8101209B2
(en)
*
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
|
US20030072802A1
(en)
*
|
2001-10-11 |
2003-04-17 |
R.T. Alamo Ventures, Inc. |
Sustained release topiramate
|
|
US20030091630A1
(en)
*
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
|
US7815936B2
(en)
*
|
2001-10-30 |
2010-10-19 |
Evonik Degussa Gmbh |
Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
|
|
US6682759B2
(en)
*
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
|
US6559293B1
(en)
*
|
2002-02-15 |
2003-05-06 |
Transform Pharmaceuticals, Inc. |
Topiramate sodium trihydrate
|
|
EP1478400A1
(en)
*
|
2002-02-26 |
2004-11-24 |
Ortho-McNeil Pharmaceutical, Inc. |
Therapy for the treatment of migraine comprising anticonvulsant derivatives and antimigraine agents
|
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
|
NZ537543A
(en)
*
|
2002-07-29 |
2007-08-31 |
Alza Corp |
Formulations and high dose osmotic dosage forms for controlled delivery of topiramate
|
|
US8216609B2
(en)
*
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
|
US7985422B2
(en)
*
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
|
US8268352B2
(en)
*
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
|
RU2005109909A
(ru)
*
|
2002-09-04 |
2006-10-10 |
Рэнбакси Лабораториз Лимитед (In) |
Лекарственные формы с замаскированным вкусом и способы их получения
|
|
US20040132826A1
(en)
*
|
2002-10-25 |
2004-07-08 |
Collegium Pharmaceutical, Inc. |
Modified release compositions of milnacipran
|
|
AU2002350719A1
(en)
*
|
2002-11-29 |
2004-06-23 |
Janssen Pharmaceutica N.V. |
Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
|
|
US7670627B2
(en)
*
|
2002-12-09 |
2010-03-02 |
Salvona Ip Llc |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
|
|
KR20050075408A
(ko)
*
|
2002-12-13 |
2005-07-20 |
시락 아게 |
트라마돌 및 토피라메이트를 포함하는 방출 조절형 제제
|
|
JP4469846B2
(ja)
*
|
2003-01-31 |
2010-06-02 |
エラン ファーマ インターナショナル，リミティド |
ナノ粒子状トピラメート製剤
|
|
US20040185097A1
(en)
*
|
2003-01-31 |
2004-09-23 |
Glenmark Pharmaceuticals Ltd. |
Controlled release modifying complex and pharmaceutical compositions thereof
|
|
WO2005016306A2
(en)
*
|
2003-08-06 |
2005-02-24 |
Alza Corporation |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
|
CA2536507A1
(en)
*
|
2003-08-22 |
2005-03-10 |
Alza Corporation |
Stepwise delivery of topiramate over prolonged period of time
|
|
CA2564227A1
(en)
*
|
2003-09-02 |
2005-03-10 |
Alza Corporation |
Novel drug compositions and dosage forms of topiramate
|
|
US7737133B2
(en)
*
|
2003-09-03 |
2010-06-15 |
Agi Therapeutics Ltd. |
Formulations and methods of treating inflammatory bowel disease
|
|
US7611728B2
(en)
*
|
2003-09-05 |
2009-11-03 |
Supernus Pharmaceuticals, Inc. |
Osmotic delivery of therapeutic compounds by solubility enhancement
|
|
DE602004032149D1
(de)
*
|
2003-09-26 |
2011-05-19 |
Alza Corp |
Oros-push-stick für die kontrollierte abgabe von wirkstoffen
|
|
ATE493981T1
(de)
*
|
2003-11-04 |
2011-01-15 |
Supernus Pharmaceuticals Inc |
Einmal tägliche dosierformen von trospium
|
|
KR20060123279A
(ko)
*
|
2003-11-13 |
2006-12-01 |
알자 코포레이션 |
용융된 블렌드 현탁액
|
|
JP2007511519A
(ja)
*
|
2003-11-14 |
2007-05-10 |
アルザ・コーポレーシヨン |
液状投薬形態物におけるトピラメートの制御放出
|
|
US7387793B2
(en)
*
|
2003-11-14 |
2008-06-17 |
Eurand, Inc. |
Modified release dosage forms of skeletal muscle relaxants
|
|
WO2005053612A2
(en)
|
2003-11-26 |
2005-06-16 |
Shire Laboratories, Inc. |
Micellar systems useful for delivery of lipophilic or hydrophobic compounds
|
|
EP1703894A1
(en)
*
|
2003-12-23 |
2006-09-27 |
ALZA Corporation |
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
|
|
WO2005065648A2
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation, Inc., |
Novel drug compositions and dosage forms of topiramate
|
|
KR100716410B1
(ko)
|
2004-07-22 |
2007-05-11 |
(주)아모레퍼시픽 |
토피라메이트 서방성 제제 및 그의 제조방법
|
|
US20060034927A1
(en)
*
|
2004-08-04 |
2006-02-16 |
Gemma Casadevall |
Means of delivering drugs in an ascending zero order release pattern
|
|
US20060105045A1
(en)
*
|
2004-11-08 |
2006-05-18 |
Buchanan Charles M |
Cyclodextrin solubilizers for liquid and semi-solid formulations
|
|
US20060121112A1
(en)
*
|
2004-12-08 |
2006-06-08 |
Elan Corporation, Plc |
Topiramate pharmaceutical composition
|
|
US20060233892A1
(en)
|
2005-04-19 |
2006-10-19 |
Curt Hendrix |
Topiramate compositions for treatment of headache
|
|
US8784886B2
(en)
*
|
2006-03-09 |
2014-07-22 |
GlaxoSmithKline, LLC |
Coating capsules with active pharmaceutical ingredients
|
|
WO2008027557A2
(en)
*
|
2006-08-31 |
2008-03-06 |
Spherics, Inc. |
Topiramate compositions and methods of enhancing its bioavailability
|
|
US8298576B2
(en)
*
|
2006-11-17 |
2012-10-30 |
Supernus Pharmaceuticals, Inc. |
Sustained-release formulations of topiramate
|